New and established technology in focal ablation of the prostate: a systematic review

M Valerio, Y Cerantola, SE Eggener, H Lepor… - European urology, 2017 - Elsevier
Context Focal therapy of prostate cancer has been proposed as an alternative to whole-
gland treatments. Objective To summarize the evidence regarding sources of energy …

The evolution of brachytherapy for prostate cancer

NG Zaorsky, BJ Davis, PL Nguyen… - Nature Reviews …, 2017 - nature.com
Abstract Brachytherapy (BT), using low-dose-rate (LDR) permanent seed implantation or
high-dose-rate (HDR) temporary source implantation, is an acceptable treatment option for …

Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study

AR Rastinehad, H Anastos, E Wajswol… - Proceedings of the …, 2019 - National Acad Sciences
Biocompatible gold nanoparticles designed to absorb light at wavelengths of high tissue
transparency have been of particular interest for biomedical applications. The ability of such …

[HTML][HTML] A multicentre study of 5-year outcomes following focal therapy in treating clinically significant nonmetastatic prostate cancer

S Guillaumier, M Peters, M Arya, N Afzal, S Charman… - European urology, 2018 - Elsevier
Background Clinically significant nonmetastatic prostate cancer (PCa) is currently treated
using whole-gland therapy. This approach is effective but can have urinary, sexual, and …

Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part II: recommended approaches and details of specific care options

MG Sanda, JA Cadeddu, E Kirkby, RC Chen… - The Journal of …, 2018 - auajournals.org
Purpose: This guideline is structured to provide a clinical framework stratified by cancer
severity to facilitate care decisions and guide the specifics of implementing the selected …

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3 …

AR Azzouzi, S Vincendeau, E Barret, A Cicco… - The Lancet …, 2017 - thelancet.com
Background Vascular-targeted photodynamic therapy, a novel tissue-preserving treatment
for low-risk prostate cancer, has shown favourable safety and efficacy results in single-arm …

Joint prostate cancer detection and Gleason score prediction in mp-MRI via FocalNet

R Cao, AM Bajgiran, SA Mirak… - IEEE transactions on …, 2019 - ieeexplore.ieee.org
Multi-parametric MRI (mp-MRI) is considered the best non-invasive imaging modality for
diagnosing prostate cancer (PCa). However, mp-MRI for PCa diagnosis is currently limited …

Stimulated Raman scattering microscopy enables gleason scoring of prostate core needle biopsy by a convolutional neural network

J Ao, X Shao, Z Liu, Q Liu, J Xia, Y Shi, L Qi, J Pan, M Ji - Cancer Research, 2023 - AACR
Focal therapy (FT) has been proposed as an approach to eradicate clinically significant
prostate cancer while preserving the normal surrounding tissues to minimize treatment …

[HTML][HTML] Focal therapy: patients, interventions, and outcomes—a report from a consensus meeting

IA Donaldson, R Alonzi, D Barratt, E Barret, V Berge… - European urology, 2015 - Elsevier
Background Focal therapy as a treatment option for localized prostate cancer (PCa) is an
increasingly popular and rapidly evolving field. Objective To gather expert opinion on patient …

Focal therapy in primary localised prostate cancer: the European Association of Urology position in 2018

HG van der Poel, RCN van den Bergh, E Briers… - European urology, 2018 - Elsevier
Radical treatment of localised prostate cancer is recognised to be an unnecessary
intervention or overtreatment in many men. Consequently, there has been a rapid uptake in …